NKTX
Nkarta, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.75
−2.78%Leverage
- Debt / equity
- 0.30x
- Net debt / equity
- 0.20x
- Debt / assets
- 0.22x
- Debt / EBITDA
- -0.68x
- Net debt / EBITDA
- -0.45x
Liquidity & coverage
- Current ratio
- 7.98x
- Quick ratio
- 7.98x
- Cash ratio
- 7.76x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $164.5M
Cash & dividend
- FCF / debt
- -1.28x
- Cash flow / debt
- -1.26x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026